Related Experiment Video
Updated: May 27, 2026
08:45
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Squalene monooxygenase - a target for hypercholesterolemic therapy.
Agnieszka Belter1, Miroslawa Skupinska, Malgorzata Giel-Pietraszuk
1Institute of Bioorganic Chemistry, Polish Academy of Science, Noskowskiego 12/14, 61-704 Poznan, Poland.
Biological Chemistry
|November 5, 2011
Summary
Squalene monooxygenase is a key enzyme in sterol synthesis and a promising target for new cholesterol-lowering drugs. Inhibitors of this enzyme offer potential advantages over current statin therapies for hypercholesterolemia.
Area of Science:
- Biochemistry
- Enzymology
- Pharmacology
Background:
- Squalene monooxygenase (SM) is crucial for sterol biosynthesis, catalyzing squalene epoxidation to 2,3-oxidosqualene.
- SM is a regulatory point in sterol synthesis; its downregulation impacts cholesterol and ergosterol production.
- SM inhibitors are clinically used for fungal infections, and mammalian SM is a target for hypercholesterolemia therapies.
Purpose of the Study:
- To review squalene monooxygenase activity, structure, and inhibitors.
- To compare current cholesterol-lowering strategies with emerging approaches.
- To highlight the advantages and safety considerations of SM as a therapeutic target for hypercholesterolemia.
Main Methods:
- Literature review of squalene monooxygenase and its inhibitors.
- Comparative analysis of hypolipidemic drug strategies.
- Discussion of clinical safety and efficacy data.
Main Results:
- Squalene monooxygenase is a validated target for hypercholesterolemia and antifungal therapies.
- Existing fungal SM inhibitors demonstrate therapeutic potential.
- New research indicates SM inhibitors could offer an alternative to statins.
Conclusions:
- Squalene monooxygenase inhibitors represent a promising future direction for hypercholesterolemia treatment.
- Further investigation into SM inhibitors is warranted due to limitations of current statin therapies.
- SM inhibition offers a potential strategy for managing cholesterol levels with improved safety profiles.
Related Concept Videos
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:22Cholinesterases: Distribution and Function
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
02:44Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
Alkenes are converted to 1,2-diols or glycols through a process called dihydroxylation. It involves the addition of two hydroxyl groups across the double bond with two different stereochemical approaches, namely anti and syn. Dihydroxylation using osmium tetroxide progresses with syn stereochemistry.
01:17Oxidation of Phenols to Quinones
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...